Now that conflict of interest rules at universities often prevent many real top experts from taking drug company speaking fees, and because many of those experts have given up the money because they are afraid it will hurt their reputation, the people giving these speeches are not always really the best and the brightest.

FORBES: The Best Bits Of ProPublica's Pharma Payroll Investigation